NCT07788664
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07788664
Title Local and Systemic Immune Modulation by Rilvegostomig (AZD2936) in the Treatment of Advanced Gastric Cancer (RILVE Project) (RILVE)
Acronym RILVE
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Vall d'Hebron Institute of Oncology
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Universitari Vall D Hebron Barcelona Catalonia 08035 Spain Details
Clinica Universidad De Navarra Madrid Madrid 28027 Spain Details
Clinica Universidad De Navarra Pamplona Navarre 31008 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field